{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:06:37Z","timestamp":1789056397061,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","award":["PID2024-161554OB-C22"],"award-info":[{"award-number":["PID2024-161554OB-C22"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","award":["PID2021-125077OB-C22"],"award-info":[{"award-number":["PID2021-125077OB-C22"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201811","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:25:24Z","timestamp":1783700724000},"page":"201811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The potential of gene therapy to rescue telomeric and extratelomeric defects in X-linked dyskeratosis congenita"],"prefix":"10.1016","volume":"34","author":[{"given":"Diego","family":"Llorente-Arroyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luz","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Perona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3228-7013","authenticated-orcid":false,"given":"Juan Antonio","family":"Bueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-0895","authenticated-orcid":false,"given":"Guillermo","family":"Guenechea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6464-5970","authenticated-orcid":false,"given":"Nestor Wenceslao","family":"Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201811_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41525-021-00198-5","article-title":"Telomere biology disorders","volume":"6","author":"Kam","year":"2021","journal-title":"npj Genom. Med."},{"key":"10.1016\/j.omta.2026.201811_bib2","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.014017","article-title":"Molecular mechanisms of telomere biology disorders","volume":"296","author":"Grill","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201811_bib3","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/s44321-024-00122-1","article-title":"The gray boundaries of aberrant shortening of the cellular timekeepers\u2019 edges","volume":"16","author":"Guenechea","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omta.2026.201811_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474086.2022.2108784","article-title":"The biology and management of dyskeratosis congenita and related disorders of telomeres","volume":"15","author":"Tummala","year":"2022","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.omta.2026.201811_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41576-022-00527-z","article-title":"Genetics of human telomere biology disorders Genetics of human telomere biology disorders","volume":"24","author":"Revy","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omta.2026.201811_bib6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1261\/rna.078953.121","article-title":"Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance","volume":"27","author":"Garus","year":"2021","journal-title":"RNA"},{"key":"10.1016\/j.omta.2026.201811_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315189","article-title":"Many Functions of Telomerase Components: Certainties, Doubts, and Inconsistencies","volume":"23","author":"Udroiu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2026.201811_bib8","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s11033-018-4496-x","article-title":"The non-canonical functions of telomerase: to turn off or not to turn off","volume":"46","author":"Romaniuk","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.omta.2026.201811_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1182\/blood.2020006481","article-title":"Inherited bone marrow failure in the pediatric patient","volume":"140","author":"Dokal","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201811_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrg1656","article-title":"Telomeres and human disease: ageing, cancer and beyond","volume":"6","author":"Blasco","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omta.2026.201811_bib11","doi-asserted-by":"crossref","first-page":"10245","DOI":"10.1074\/jbc.REV119.009710","article-title":"Extra-telomeric impact of telomeres: Emerging molecular connections in pluripotency or stemness","volume":"295","author":"Vinayagamurthy","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201811_bib12","first-page":"943","article-title":"Dyskeratosis congenita: a literature review","volume":"18","author":"AlSabbagh","year":"2020","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"10.1016\/j.omta.2026.201811_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.13442","article-title":"Unraveling the Pathogenesis of Hoyeraal-Hreidarsson Syndrome, a Complex Telomere Biology Disorder","volume":"170","author":"Glousker","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omta.2026.201811_bib14","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/blood.2021013523","article-title":"Disease progression and clinical outcomes in telomere biology disorders","volume":"139","author":"Niewisch","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201811_bib15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","article-title":"An update on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"12","author":"Niewisch","year":"2019","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.omta.2026.201811_bib16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germline mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201811_bib17","unstructured":"Home - OMIM https:\/\/www.omim.org\/."},{"key":"10.1016\/j.omta.2026.201811_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omta.2026.201811_bib19","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood-2005-07-2622","article-title":"Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation","volume":"107","author":"Vulliamy","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201811_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg1805","article-title":"Control of protein synthesis through mRNA pseudouridylation by dyskerin","volume":"9","author":"Pederiva","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omta.2026.201811_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.949435","article-title":"Fanconi anemia and dyskeratosis congenita\/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability","volume":"12","author":"Fiesco-Roa","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omta.2026.201811_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2010.07.021","article-title":"Androgens stimulate telomerase expression, activity and phosphorylation in ovarian adenocarcinoma cells","volume":"330","author":"Nourbakhsh","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.omta.2026.201811_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bjh.12748","article-title":"Response to androgen therapy in patients with dyskeratosis congenita","volume":"165","author":"Khincha","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omta.2026.201811_bib24","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2016.03.001","article-title":"Survival after Hematopoietic Stem Cell Transplant in Patients with Dyskeratosis Congenita: Systematic Review of the Literature","volume":"22","author":"Barbaro","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omta.2026.201811_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/MOH.0000000000000290","article-title":"Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita","volume":"23","author":"Elmahadi","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.omta.2026.201811_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/bjh.15495","article-title":"Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita","volume":"183","author":"Fioredda","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omta.2026.201811_bib27","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/bloodadvances.2018021162","article-title":"Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment","volume":"2","author":"Georges","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.omta.2026.201811_bib28","first-page":"1005.e1","article-title":"Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita\/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation. Transplant","volume":"30","author":"Dimitrov","year":"2024","journal-title":"Cell. Ther"},{"key":"10.1016\/j.omta.2026.201811_bib29","doi-asserted-by":"crossref","first-page":"10646","DOI":"10.1182\/blood-2022-168342","article-title":"Lentiviral-mediated Gene Therapy for Patients with Fanconi Anemia [Group A]: Updated Results from Global RP-L102 Clinical Trials","volume":"140","author":"Czechowicz","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201811_bib30","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/S0140-6736(24)01880-4","article-title":"Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1\/2 (FANCOLEN-1) and long-term clinical trials","volume":"404","author":"R\u00edo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2026.201811_bib31","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/s41591-019-0550-z","article-title":"Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia","volume":"25","author":"R\u00edo","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201811_bib32","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4161\/cc.21506","article-title":"Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence","volume":"11","author":"McKenna","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.omta.2026.201811_bib33","doi-asserted-by":"crossref","first-page":"19068","DOI":"10.1074\/jbc.M109.040477","article-title":"Mitomycin C inhibits ribosomal RNA: a novel cytotoxic mechanism for bioreductive drugs","volume":"285","author":"Snodgrass","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201811_bib34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/nar\/gkz637","article-title":"Hallmarks of ribosomopathies","volume":"48","author":"Kampen","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2026.201811_bib35","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3390\/cells9092080","article-title":"Ribosomopathies: New Therapeutic Perspectives","volume":"9","author":"Orgebin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omta.2026.201811_bib36","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1096\/fj.15-270991","article-title":"Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation","volume":"29","author":"Penzo","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.omta.2026.201811_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2024.102204","article-title":"Exploring the role of ribosomal RNA modifications in cancer","volume":"86","author":"L\u00f3pez","year":"2024","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.omta.2026.201811_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.778778","article-title":"Coupling Between Production of Ribosomal RNA and Maturation: Just at the Beginning","volume":"8","author":"Azouzi","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omta.2026.201811_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/path.2023","article-title":"Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer","volume":"210","author":"Montanaro","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.omta.2026.201811_bib40","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/2211-5463.13444","article-title":"Mutations in RPS19 may affect ribosome function and biogenesis in Diamond Blackfan anemia","volume":"12","author":"Hiregange","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.omta.2026.201811_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.171650","article-title":"Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemia","volume":"9","author":"Gim\u00e9nez","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.omta.2026.201811_bib42","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/v13081526","article-title":"Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases","volume":"13","author":"Poletti","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.omta.2026.201811_bib43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nsmb.3184","article-title":"Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects","volume":"23","author":"Shukla","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omta.2026.201811_bib44","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1101\/gad.1476206","article-title":"Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita","volume":"20","author":"Wong","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.omta.2026.201811_bib45","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.stem.2020.03.016","article-title":"Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells","volume":"26","author":"Nagpal","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201811_bib46","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/mt.2015.180","article-title":"Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering","volume":"23","author":"Jung","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201811_bib47","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41434-023-00390-5","article-title":"Successes and challenges in clinical gene therapy","volume":"30","author":"Kohn","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201811_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28762-2","article-title":"A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders","volume":"13","author":"Tucci","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201811_bib49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/cge.13593","article-title":"Advances in the gene therapy of monogenic blood cell diseases","volume":"97","author":"Bueren","year":"2020","journal-title":"Clin. Genet."},{"key":"10.1016\/j.omta.2026.201811_bib50","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood-2017-03-774174","article-title":"Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients","volume":"130","author":"R\u00edo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201811_bib51","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1182\/blood-2007-10-120204","article-title":"Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita","volume":"111","author":"Goldman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201811_bib52","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2141.2008.06991.x","article-title":"Circulating haematopoietic progenitors are differentially reduced amongst subtypes of dyskeratosis congenita","volume":"140","author":"Kirwan","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omta.2026.201811_bib53","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbmt.2016.01.026","article-title":"A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation","volume":"22","author":"Nelson","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omta.2026.201811_bib54","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jcp.56.8.583","article-title":"Enhanced telomere shortening in transformed lymphoblasts from patients with X linked dyskeratosis","volume":"56","author":"Montanaro","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.omta.2026.201811_bib55","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03573","article-title":"The dyskerin ribonucleoprotein complex as an OCT4\/SOX2 coactivator in embryonic stem cells","volume":"3","author":"Fong","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.omta.2026.201811_bib56","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1182\/blood-2011-04-351460","article-title":"A zebrafish model of dyskeratosis congenita reveals hematopoietic stem cell formation failure resulting from ribosomal protein-mediated p53 stabilization","volume":"118","author":"Pereboom","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201811_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118845","article-title":"Acute depletion of telomerase components DKC1 and NOP10 induces oxidative stress and disrupts ribosomal biogenesis via NPM1 and activation of the P53 pathway","volume":"1867","author":"Ib\u00e1\u00f1ez-Cabellos","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.omta.2026.201811_bib58","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1038\/s41467-021-27206-7","article-title":"Hematopoiesis under telomere attrition at the single-cell resolution","volume":"12","author":"Thongon","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201811_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23375","article-title":"CD8+ T-cell senescence and skewed lymphocyte subsets in young Dyskeratosis Congenita patients with PARN and DKC1 mutations","volume":"34","author":"Zeng","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.omta.2026.201811_bib60","doi-asserted-by":"crossref","first-page":"eadr5817","DOI":"10.1126\/science.adr5817","article-title":"Cryo-EM structure of human telomerase dimer reveals H\/ACA RNP-mediated dimerization","volume":"389","author":"Balch","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.omta.2026.201811_bib61","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.celrep.2013.04.030","article-title":"H\/ACA Small RNA Dysfunctions in Disease Reveal Key Roles for Noncoding RNA Modifications in Hematopoietic Stem Cell Differentiation","volume":"3","author":"Bellodi","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.omta.2026.201811_bib62","article-title":"Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients","volume":"10","author":"Gu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201811_bib63","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.3390\/cancers12123512","article-title":"DKC1 Overexpression Induces a More Aggressive Cellular Behavior and Increases Intrinsic Ribosomal Activity in Immortalized Mammary Gland Cells","volume":"12","author":"Guerrieri","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omta.2026.201811_bib64","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400252","article-title":"Clinical Use of ZSCAN4 for Telomere Elongation in Hematopoietic Stem Cells","volume":"4","author":"Myers","year":"2025","journal-title":"NEJM Evid."},{"key":"10.1016\/j.omta.2026.201811_bib65","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112699","article-title":"Ribosome biogenesis factors\u2014from names to functions","volume":"42","author":"D\u00f6rner","year":"2023","journal-title":"EMBO J."},{"key":"10.1016\/j.omta.2026.201811_bib66","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/nprot.2006.263","article-title":"Flow cytometry and FISH to measure the average length of telomeres (flow FISH)","volume":"1","author":"Baerlocher","year":"2006","journal-title":"Nat. Protoc."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:11:26Z","timestamp":1789053086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001461"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201811","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of gene therapy to rescue telomeric and extratelomeric defects in X-linked dyskeratosis congenita","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201811"}}